Home page > Products > Lamzede®
 

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Lamzede®

active ingredient: Velmanase alfa

Enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis.

 

For more information about therapy you can find on the corporate webs Chiesi Global Rare Diseases.